2025 年 4 月 17 日，浙江大学医学院黄河教授、胡永仙教授团队在国际顶级肿瘤学期刊 《JAMA Oncology》发表了题为「Dasatinib and CAR T-Cell Therapy in Newly Diagnosed Ph-Positive Acute Lymphoblastic Leukemia」的重要研究成果。

The results highlight an in vivo patient-derived xenograft (PDX) model of relapsed/refractory T-PLL that reproduced key human clinicopathological features of the disease. In this model, SLS009 ...

A 12-year-old girl diagnosed with acute lymphoblastic leukemia was successfully treated for the first time with CAR-T immune cell therapy by doctors at the Ho Chi Minh City Blood Transfusion and ...

Haplo-cord HCT offered improved 2-year OS (72.7% vs 61.0%) and DFS (67.0% vs 49.6%) compared with haplo HCT alone.

With guidance from Dr. Soumya Bhattacharya and Dr. Rajat Bhattacharyya, both senior consultants in Haematology and Hemato-oncology, the patient was enrolled for CAR-T cell therapy. The treatment used ...

October 12, 2025 - PORTERVILLE, Calif. — A cutting-edge cancer treatment that reprograms the body’s own immune cells saved a Porterville child’s life — and it’s coming soon to Valley Children’s, ...

Cancers driven by hiccups in RNA processing can’t hide from our immune system, according to new work published today in Cell. A cross-institutional team Fred Hutch Cancer Center and Memorial Sloan ...

Mid Valley High School graduate Eddie Kaufman was always a team player, whether on the baseball field or the golf course. When Kaufman, a All-Region baseball player and golfer, was diagnosed with ...

Eddie Kaufman played hard on the field, but fought even harder off the diamond before losing his fight with leukemia at the ...